Histolix provides an intrinsically digital and slide-free histopathology solution.
Histolix has raised $3.2M in total funding. The most recent round was Grant. The last funding was announced in June 2023.
Histolix's investors include National Cancer Institute.
Histolix is headquartered in Sacramento, United States.
Histolix provides an intrinsically digital and slide-free histopathology solution.
Histolix is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Histolix — Funding & Investors." VCBacked, June 28, 2023, https://www.vcbacked.co/company/histolix. Accessed September 30, 2026.
VCBacked. (2023). Histolix — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/histolix
{{cite web |title=Histolix — Funding & Investors |url=https://www.vcbacked.co/company/histolix |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated